Amid an epidemic of opioid addiction and suicide, ketamine wellness centers have been emerging as a source of hope for many in Arizona and across the nation. However, the surge of these centers has been brought to a halt as the Federal Drug Administration (FDA) has recently ordered the closure of all ketamine wellness centers in the state and other areas of the country.
Ketamine, an anesthetic used for medical procedures, has been found to have a variety of beneficial effects for those suffering from depression, anxiety, and post-traumatic stress disorder (PTSD). The drug works rapidly, typically within hours of administering it, to reduce symptoms and improve quality of life. Its meteoric rise as a popular medical treatment has led to the proliferation of clinics that are dedicated to administering the drug.
The FDA’s decision to shutter these wellness centers was spurred by reports of adverse effects experienced by some patients, such as high blood pressure, increased heart rate, and confusion. Further, the FDA expressed concerns that these clinics are providing ketamine without proper medical oversight and that the drug is being used in a manner that is inconsistent with its approved uses.
As the FDA moves to shut down these ketamine wellness centers, patients who have been utilizing the drug to manage their mental health issues are left in a difficult situation. Without access to ketamine, many may be forced to resort to other potentially dangerous treatments such as opioids or other drugs that can be addictive and have potentially life-threatening side effects.
While the FDA’s decision to close these clinics is understandable, it leaves a large gap in the health care system for those who were depending on ketamine for relief from their mental health issues. Going forward, the FDA must consider ways to ensure that ketamine is administered safely and effectively, while also providing access to those who need it.